应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
WXXWY 药明生物ADR
盘前交易 02-04 16:00:00 EST 延时
资讯
新帖
简况
智通港股早知道 | 财政部召开财政金融协同促内需会议 白宫宣布对特定半导体等加征25%关税
智通财经 · 01-15
智通港股早知道 | 财政部召开财政金融协同促内需会议 白宫宣布对特定半导体等加征25%关税
【特约大V】邓声兴：AI概念股热炒，恒指升势未止
金吾财讯 · 01-13
【特约大V】邓声兴：AI概念股热炒，恒指升势未止
美股三大指数齐升 恒指50天线料有不俗支援
真灼财经 · 01-12
美股三大指数齐升 恒指50天线料有不俗支援
智通决策参考︱留意本周台积电(TSM.US)财报 商业航天无疑是最强主线
智通财经 · 01-12
智通决策参考︱留意本周台积电(TSM.US)财报 商业航天无疑是最强主线
美国OTC市场药明生物ADR盘中异动 股价大涨5.75%报8.28美元
市场透视 · 2025-11-24
美国OTC市场药明生物ADR盘中异动 股价大涨5.75%报8.28美元
美国OTC市场药明生物ADR盘中异动 早盘急速拉升6.41%报9.63美元
市场透视 · 2025-10-13
美国OTC市场药明生物ADR盘中异动 早盘急速拉升6.41%报9.63美元
美国OTC市场药明生物ADR盘中异动 早盘大幅下挫5.38%报9.84美元
市场透视 · 2025-10-10
美国OTC市场药明生物ADR盘中异动 早盘大幅下挫5.38%报9.84美元
美国OTC市场药明生物ADR盘中异动 股价大涨5.59%报10.58美元
市场透视 · 2025-09-29
美国OTC市场药明生物ADR盘中异动 股价大涨5.59%报10.58美元
药明生物ADR8月11日成交额为3.98万美元
市场透视 · 2025-08-12
药明生物ADR8月11日成交额为3.98万美元
药明生物ADR8月8日成交额为27.78万美元
市场透视 · 2025-08-09
药明生物ADR8月8日成交额为27.78万美元
药明生物ADR8月7日成交额为45.51万美元
市场透视 · 2025-08-08
药明生物ADR8月7日成交额为45.51万美元
药明生物再次通过日本PMDA GMP检查 累计通过42次全球药品监管机构检查
美通社 · 2025-02-27
药明生物再次通过日本PMDA GMP检查 累计通过42次全球药品监管机构检查
药明生物连续两年问鼎EcoVadis可持续发展"铂金"评级
美通社 · 2025-02-18
药明生物连续两年问鼎EcoVadis可持续发展"铂金"评级
药明生物连续五年获评晨星Sustainalytics ESG"行业最高评级"及"区域最高评级"
美通社 · 2025-02-10
药明生物连续五年获评晨星Sustainalytics ESG"行业最高评级"及"区域最高评级"
药明生物和Candid Therapeutics就T细胞衔接子三特异性抗体达成研究服务合作
美通社 · 2025-01-07
药明生物和Candid Therapeutics就T细胞衔接子三特异性抗体达成研究服务合作
药明生物成功入选UNGC"‘二十年二十佳'企业可持续发展案例"报告
美通社 · 2024-12-12
药明生物成功入选UNGC"‘二十年二十佳'企业可持续发展案例"报告
药明生物爱尔兰基地再迎多项里程碑：多个16000L规模PPQ生产批次成功并获HPRA GMP认证
美通社 · 2024-12-06
药明生物爱尔兰基地再迎多项里程碑：多个16000L规模PPQ生产批次成功并获HPRA GMP认证
药明生物德国基地计划扩大产能 新增预充针制剂灌装生产线
美通社 · 2024-11-14
药明生物德国基地计划扩大产能 新增预充针制剂灌装生产线
药明生物推出技术平台WuXia™ RidGS，赋能客户研发非抗生素细胞株
美通社 · 2024-10-28
药明生物推出技术平台WuXia™ RidGS，赋能客户研发非抗生素细胞株
加载更多
公司概况
公司名称：
药明生物ADR
所属市场：
PINK LIMITED
上市日期：
--
主营业务：
药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联（XDC）分部主要从事为抗体偶联药物（ADCs）及各种生物偶联药物提供合同研究、开发及生产组织（CRDMO）服务。该公司主要在国内和国外市场开展其业务。
发行价格：
--
{"stockData":{"symbol":"WXXWY","market":"US","secType":"STK","nameCN":"药明生物ADR","latestPrice":9.35,"timestamp":1770238800000,"preClose":9.3605,"halted":0,"volume":87929,"delay":15,"changeRate":-0.0011217349500561294,"floatShares":1789280026,"shares":2066789506,"eps":0.214998,"marketStatus":"盘前交易","change":-0.0105,"latestTime":"02-04 16:00:00 EST 延时","open":9.73,"high":9.73,"low":9.16,"amount":818858.2789,"amplitude":0.060894,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.214998,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770301800000},"marketStatusCode":1,"adr":0,"adrRate":2,"exchange":"PINK LIMITED","adjPreClose":9.35,"volumeRatio":2.171601179313818},"requestUrl":"/m/hq/s/WXXWY","defaultTab":"news","newsList":[{"id":"2603462820","title":"智通港股早知道 | 财政部召开财政金融协同促内需会议 白宫宣布对特定半导体等加征25%关税","url":"https://stock-news.laohu8.com/highlight/detail?id=2603462820","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603462820?lang=zh_cn&edition=full","pubTime":"2026-01-15 07:40","pubTimestamp":1768434028,"startTime":"0","endTime":"0","summary":"参加会议的包括国务院有关部门和单位、省级财政部门、财政部各地监管局以及相关经办机构。美国白宫宣布对特定半导体等加征25%关税美国白宫14日宣布，从15日起对部分进口半导体、半导体制造设备和衍生品加征25%的进口从价关税。根据该通知书，市监总局已根据中华人民共和国反垄断法开始对本公司进行调查。经本公司财务部门初步测算，预计2025年度实现归属于上市公司股东的扣除","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a7a093e7059d2a399d631855b31ce739","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300759","BK1584","BK1591","BK1142","BK1516","BK1502","02269","LU1794554557.SGD","BK1501","BK1189","BK1521","BK1589","BK1515","BK1610","09688","TCOM","BK1615","02268","BK4585","01875","BK1617","BK1147","WXXWY","BK1571","BK4588","ZLAB","09961","SMH","BK1247","SOXX","03759","LU1720050803.USD","BK1564"],"gpt_icon":1},{"id":"2603794735","title":"【特约大V】邓声兴：AI概念股热炒，恒指升势未止","url":"https://stock-news.laohu8.com/highlight/detail?id=2603794735","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603794735?lang=zh_cn&edition=full","pubTime":"2026-01-13 11:21","pubTimestamp":1768274518,"startTime":"0","endTime":"0","summary":"国指升171点或1.9%，报9220点；科指升176点或3.1%，报5863点。利福中国拟向股东派发特别息，股价飙升37.3%，报0.92元。Meta回吐1.7%，集团据报计划在Reality Labs业务部门裁员约10%，将部分VR产品资金调拨到穿戴式装置。AI概念股热炒，恒指升势未止。数字孪生平台，深度融合AI与过程分析技术，提升研发效率与工艺一致性，强化竞争护城河。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZjAzYmQ0ZTAxMjgwMmU1OWFmMjcwNDc3NDA4NDI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZjAzYmQ0ZTAxMjgwMmU1OWFmMjcwNDc3NDA4NDI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973109","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK4614","LU0348825331.USD","LU0516423174.USD","LU0572944931.SGD","LU0819121731.USD","HHImain","BK1589","LU0417516738.SGD","LU0456827905.SGD","LU1794554557.SGD","LU2039709279.SGD","LU0516422952.EUR","LU0823426308.USD","LU0326950275.SGD","LU0856984785.SGD","LU0327786744.USD","LU0320764599.SGD","LU0039217434.USD","LU0516423091.SGD","LU1242518857.USD","603501","MCHmain","LU0516422440.USD","LU0823426480.USD","LU0043850808.USD","LU0588546209.SGD","LU0979878070.USD","BK1521","LU0181495838.USD","LU0516422366.SGD","LU0456846285.SGD","SG9999002463.SGD","BK1141","LU0708995583.HKD","LU0051755006.USD","02269","SG9999002562.SGD","WXXWY","02833","LU0359201612.USD","LU1242518931.SGD","IE00B0JY6N72.USD","LU0359202008.SGD","LU0417516902.SGD","LU1720050803.USD","LU0307460666.USD","BK1610","513600","LU3063872942.SGD","LU0052750758.USD","LU0140636845.USD","LU1688375341.USD","LU0348735423.USD","LU1880383366.USD"],"gpt_icon":1},{"id":"2602482545","title":"美股三大指数齐升 恒指50天线料有不俗支援","url":"https://stock-news.laohu8.com/highlight/detail?id=2602482545","media":"真灼财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602482545?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:45","pubTimestamp":1768221940,"startTime":"0","endTime":"0","summary":"美股三大指数上周五造好，纳指表现最佳升0.95%，道指及标普500指数则分别上升0.48%及0.65%，反映中概股表现之金龙指数则跌至1.3%。A股上周五继续有表现，上综指及深成成指分别上升0.92%及1.15%，收报4,120点及14,120点，成交金额达到3.12万亿元人民币，全周计则上综指升3.8%，深成指升幅则达到4.4%。虽然恒指上周下跌，不过整体形势并非太差，现时亦续企稳50天线水准；短期只要守稳该水准，则后市仍有望延续反弹，并挑战26,800点水准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112213227a711d5a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112213227a711d5a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NTES","SCHYY","03692","MHImain","513600","SPY","HSTECH","00241","TQQQ","603259","06618","HSI","01928","MCHmain","01801","QQQ","02359","02269","HHImain","WXXWY","000001","02833","09999"],"gpt_icon":1},{"id":"2602696705","title":"智通决策参考︱留意本周台积电(TSM.US)财报 商业航天无疑是最强主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2602696705","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602696705?lang=zh_cn&edition=full","pubTime":"2026-01-12 09:06","pubTimestamp":1768179986,"startTime":"0","endTime":"0","summary":"1月11日获悉，美国官员称，美国总统特朗普正在考虑干涉伊朗的多种方案。美国最高法院推迟对特朗普关税案件判决，下次判决将在本周14日。1月14日周三，美联储发布关于地区经济状况的最新褐皮书调查。注意一下台积电周四的财报是全球AI产业链的“风向标”。热点方向，商业航天无疑是最强主线，据最新消息，国际电信联盟官网显示，中国提交了新增20.3万颗的卫星申请，此次申报涵盖14个卫星星座。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1720050803.USD","BK4503","LU2237443622.USD","LU2237443978.SGD","BK1610","LU0238689110.USD","LU0878005551.USD","LU2250418816.HKD","LU2491049909.HKD","IE0004091025.USD","SG9999002562.SGD","LU1989772840.SGD","LU0109392836.USD","BK1587","LU1712237335.SGD","BK4591","BK4554","LU2063271972.USD","03145","IE00BQXX3F31.USD","LU1917777945.USD","LU1934455277.USD","LU0861579265.USD","LU0823414551.USD","LU0143863198.USD","LU0642271901.SGD","LU0965508806.USD","LU2543165471.USD","02269","LU0456827905.SGD","LU1316542783.SGD","LU0417516902.SGD","LU0326950275.SGD","LU0359201612.USD","LU2211815571.USD","LU1037948541.HKD","LU2247934214.USD","LU2249611893.SGD","BK4505","LU2237443549.SGD","IE0004445239.USD","LU2089283258.USD","LU0051755006.USD","SG9999000418.SGD","LU0572940350.SGD","IE00B3M56506.USD","LU0823421416.USD","LU2054465674.USD","LU0143863784.USD","LU1046422090.SGD","LU2471134879.HKD","LU2271345857.HKD","LU0052750758.USD","LU2471134796.USD","BK4602","LU0348723411.USD","LU2111349929.HKD","LU0516422440.USD","BK1141","LU0516422952.EUR","LU1989764664.SGD","LU1037948897.HKD","SGXZ51526630.SGD","TSM","LU1794554557.SGD","LU2041044095.USD","BK4141","LU0456846285.SGD","LU1868838027.USD","LU1242518931.SGD","LU2491050154.USD","LU2133065610.SGD","LU0327786744.USD","LU2663582299.SGD","SG9999002463.SGD","LU0541501648.USD","LU2750360641.GBP","LU0792757196.USD","LU0175139822.USD","LU0181495838.USD","LU0316494557.USD","BK4548","IE00BFXG0V08.USD","LU0965509283.SGD","LU1211504680.USD","BK1576","IE00BKPKM429.USD","LU2860962120.EUR","BK4534","LU2506951792.HKD","LU0979878070.USD","LU0516422366.SGD","SG9999004220.SGD","LU2458330169.SGD","IE0004086264.USD","LU0056508442.USD","LU1989772923.USD","LU0878004406.USD","LU0965509101.SGD","BK1521","LU0082616367.USD","LU2491050071.SGD","BK1589","IE00BD6J9T35.USD","LU0823421333.USD","LU2360108059.USD","LU1508157978.USD","LU0689626769.HKD","LU0572944931.SGD","LU0823426308.USD","BK4550","IE00BQXX3D17.EUR","LU1868837722.USD","LU0359201885.HKD","LU2106854487.HKD","LU0124676726.USD","LU0823426480.USD","LU1803068979.SGD","BK4526","LU0417516738.SGD","LU0541502299.USD","LU0348735423.USD","LU0516423174.USD","LU1688375341.USD","LU1880383366.USD","LU2357125470.USD","LU2092937221.SGD","LU2471134952.CNY","BK4532","LU0882747503.HKD","LU0488056044.USD","SGXZ81514606.USD","LU0384037296.USD","LU0348825331.USD","LU0140636845.USD","LU0039217434.USD","LU3063872942.SGD","LU2750360997.AUD","LU2458330243.SGD","LU1934455863.HKD","LU1974910355.USD","LU1989764748.USD","LU0965509010.AUD","LU2298321311.HKD","LU1023057109.AUD","LU2211814178.USD","LU0320764599.SGD","BK4612","LU2028103732.USD","LU0094547139.USD","LU1868837565.USD","LU2023251221.USD","BK4585","LU2471134523.USD","LU0819121731.USD","BK4527","LU2023250504.SGD","IE00B5TLWC47.USD","LU0708995583.HKD","LU0889566641.SGD","LU0307460666.USD","LU1623119135.USD","LU2360032135.SGD","LU0289960550.SGD","LU0158827781.USD","LU2039709279.SGD","LU0719512351.SGD","IE00BYQQ9H92.USD","BK4588","IE00B0JY6N72.USD","LU2089284900.SGD","LU0823414478.USD","LU2237443382.USD","LU0353189763.USD","LU0588546209.SGD","WXXWY","BK4581","LU1267930813.SGD","LU0158827948.USD","BK4605","BK4512","LU1282649067.USD","LU1242518857.USD","LU2360106780.USD","BK1219","LU0043850808.USD","IE00BQXX3C00.GBP","LU1934455194.USD","LU0889565833.HKD","IE00BZ199S13.USD","LU0264606111.USD","LU2125154778.USD","LU0516423091.SGD","LU2294711713.HKD","LU0359202008.SGD","LU0049112450.USD","LU0572939691.SGD","SGXZ99366536.SGD","IE00BHPRN162.USD","LU0353189680.USD","LU2125154935.USD","LU1235295612.USD","BK4543","LU1852331112.SGD","BK4533","LU0198837287.USD","LU2087625088.SGD","LU1282649810.SGD","LU0856984785.SGD","LU0323591593.USD","BK1189"],"gpt_icon":1},{"id":"2586403694","title":"美国OTC市场药明生物ADR盘中异动 股价大涨5.75%报8.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586403694","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586403694?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:46","pubTimestamp":1763995604,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时46分，美国OTC市场药明生物ADR股票出现异动，股价大幅拉升5.75%。截至发稿，该股报8.28美元/股，成交量1811股，换手率0.00%，振幅0.13%。美国OTC市场药明生物ADR股票所在的生物技术行业中，整体涨幅为0.54%。美国OTC市场药明生物ADR公司简介：无锡药明康德集团是一家生物药物的合同开发和制造组织，简称“CDMO”。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224644a70e9087&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224644a70e9087&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2575695253","title":"美国OTC市场药明生物ADR盘中异动 早盘急速拉升6.41%报9.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575695253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575695253?lang=zh_cn&edition=full","pubTime":"2025-10-13 22:36","pubTimestamp":1760366180,"startTime":"0","endTime":"0","summary":"北京时间2025年10月13日22时36分，美国OTC市场药明生物ADR股票出现波动，股价快速拉升6.41%。截至发稿，该股报9.63美元/股，成交量416股，换手率0.00%，振幅1.77%。美国OTC市场药明生物ADR股票所在的生物技术行业中，整体涨幅为0.31%。美国OTC市场药明生物ADR公司简介：无锡药明康德集团是一家生物药物的合同开发和制造组织，简称“CDMO”。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101322362094c6b615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101322362094c6b615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2574690437","title":"美国OTC市场药明生物ADR盘中异动 早盘大幅下挫5.38%报9.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574690437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574690437?lang=zh_cn&edition=full","pubTime":"2025-10-10 21:46","pubTimestamp":1760103988,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日21时46分，美国OTC市场药明生物ADR股票出现异动，股价急速下跌5.38%。截至发稿，该股报9.84美元/股，成交量4812股，换手率0.00%，振幅0.48%。美国OTC市场药明生物ADR股票所在的生物技术行业中，整体跌幅为0.28%。美国OTC市场药明生物ADR公司简介：无锡药明康德集团是一家生物药物的合同开发和制造组织，简称“CDMO”。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010214628a6b319bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251010214628a6b319bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2571655463","title":"美国OTC市场药明生物ADR盘中异动 股价大涨5.59%报10.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2571655463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571655463?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:42","pubTimestamp":1759156922,"startTime":"0","endTime":"0","summary":"北京时间2025年09月29日22时42分，美国OTC市场药明生物ADR股票出现波动，股价大幅上涨5.59%。截至发稿，该股报10.58美元/股，成交量251股，换手率0.00%，振幅0.00%。美国OTC市场药明生物ADR股票所在的生物技术行业中，整体涨幅为1.81%。美国OTC市场药明生物ADR公司简介：无锡药明康德集团是一家生物药物的合同开发和制造组织，简称“CDMO”。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929224202a6a68537&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929224202a6a68537&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","WXXWY"],"gpt_icon":0},{"id":"2558643957","title":"药明生物ADR8月11日成交额为3.98万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558643957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558643957?lang=zh_cn&edition=full","pubTime":"2025-08-12 16:37","pubTimestamp":1754987871,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，药明生物ADR成交额为3.98万美元，成交额较昨日减少85.67%，当日成交量为5280.00股。药明生物ADR于2025年8月11日涨0.8%，报7.56美元，该股过去5个交易日跌4.3%，年初至今涨70.65%，过去60日涨25.79%。它成立于 2010 年，隶属于药明康德，并于 2017 年在香港联交所上市。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812172909a483cece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812172909a483cece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2558219509","title":"药明生物ADR8月8日成交额为27.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558219509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558219509?lang=zh_cn&edition=full","pubTime":"2025-08-09 16:36","pubTimestamp":1754728576,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，药明生物ADR成交额为27.78万美元，成交额较昨日减少38.96%，当日成交量为3.71万股。药明生物ADR于2025年8月8日跌2.22%，报7.5美元，该股过去5个交易日跌4.21%，年初至今涨69.3%，过去60日涨27.12%。它成立于 2010 年，隶属于药明康德，并于 2017 年在香港联交所上市。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809163621a6dc4f9b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809163621a6dc4f9b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2557523564","title":"药明生物ADR8月7日成交额为45.51万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557523564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557523564?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:31","pubTimestamp":1754641891,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，药明生物ADR成交额为45.51万美元，成交额较昨日增加113.37%，当日成交量为5.91万股。药明生物ADR于2025年8月7日跌4.01%，报7.67美元，该股过去5个交易日跌6.12%，年初至今涨73.14%，过去60日涨28.05%。它成立于 2010 年，隶属于药明康德，并于 2017 年在香港联交所上市。无锡药明康德报告称，2020年收入为56亿元人民币，三年复合年增长率为51%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180511a47d074e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808180511a47d074e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WXXWY","BK4121"],"gpt_icon":0},{"id":"2514849719","title":"药明生物再次通过日本PMDA GMP检查 累计通过42次全球药品监管机构检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2514849719","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514849719?lang=zh_cn&edition=full","pubTime":"2025-02-27 12:30","pubTimestamp":1740630600,"startTime":"0","endTime":"0","summary":"无锡2025年2月27日 /美通社/ --全球领先的合同研究、开发和生产服务公司药明生物宣布，公司无锡基地的生物药原液生产厂再次通过日本药品医疗器械综合机构GMP检查。公司以零缺陷通过此次涵盖设施质量体系及生产全流程的现场检查，彰显了其在满足全球监管要求方面的卓越能力。截至目前，药明生物已累计成功通过42次全球药品监管机构检查，并获得美国、欧洲、中国、新加坡、日本及加拿大等国家和地区药监部门颁发的97项生产许可证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4628886_ZH28886_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4121","BK1610","LU1688375341.USD","LU0051755006.USD","LU0708995583.HKD","LU1242518857.USD","BK1521","LU0326950275.SGD","LU0327786744.USD","LU0348735423.USD","BK1141","LU0039217434.USD","LU0516422440.USD","LU0417516902.SGD","ESG","LU0588546209.SGD","LU1880383366.USD","LU0516423091.SGD","SG9999002463.SGD","LU0456827905.SGD","LU0516422366.SGD","LU1242518931.SGD","LU0516422952.EUR","BK1576","LU0043850808.USD","LU0979878070.USD","LU0359202008.SGD","LU0417516738.SGD","LU0348825331.USD","LU0320764599.SGD","IE00B0JY6N72.USD","LU0572944931.SGD","LU0140636845.USD","LU0823426308.USD","WXXWY","LU0456846285.SGD","LU1720050803.USD","LU2039709279.SGD","LU0181495838.USD","LU1794554557.SGD","LU0819121731.USD","LU0052750758.USD","BK1589","LU0307460666.USD","SG9999002562.SGD","LU0359201612.USD","LU0516423174.USD","02269","LU0823426480.USD","LU0856984785.SGD"],"gpt_icon":1},{"id":"2512513762","title":"药明生物连续两年问鼎EcoVadis可持续发展\"铂金\"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2512513762","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512513762?lang=zh_cn&edition=full","pubTime":"2025-02-18 17:00","pubTimestamp":1739869200,"startTime":"0","endTime":"0","summary":"EcoVadis是全球供应链领域领先的可持续发展评级机构，其评级从环境、劳工与人权、商业道德和可持续采购四大主题进行评估，下设21项可持续发展标准与7项管理指标，全面衡量企业的可持续发展表现。EcoVadis通过系统评估企业的政策制定、实施举措及成果输出，并综合第三方专家及外部利益相关方的专业意见，形成权威评级结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4621239_ZH21239_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02269","WXXWY"],"gpt_icon":1},{"id":"2510839022","title":"药明生物连续五年获评晨星Sustainalytics ESG\"行业最高评级\"及\"区域最高评级\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2510839022","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510839022?lang=zh_cn&edition=full","pubTime":"2025-02-10 17:00","pubTimestamp":1739178000,"startTime":"0","endTime":"0","summary":"Sustainalytics作为一家知名的ESG数据、研究与评级机构，致力于为全球投资者制定和实施负责任的投资战略。其2025年ESG风险评级覆盖了全球42个行业15000多家企业，并从中评选出在ESG领域取得卓越成就的公司授予\"最高评级\"荣誉。药明生物在制药行业评选中脱颖而出，位列前1%，彰显了其在ESG领域的杰出表现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4615304_ZH15304_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["02269","ESG","WXXWY"],"gpt_icon":1},{"id":"2501219392","title":"药明生物和Candid Therapeutics就T细胞衔接子三特异性抗体达成研究服务合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2501219392","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501219392?lang=zh_cn&edition=full","pubTime":"2025-01-07 08:00","pubTimestamp":1736208000,"startTime":"0","endTime":"0","summary":"上海和圣地亚哥2025年1月7日 /美通社/ -- 全球领先的合同研究、开发和生产服务公司药明生物今日宣布与Candid Therapeutics已达成研究服务合作协议。根据协议，Candid公司将拥有一款处于临床前开发阶段的三特异性抗体的全球权益。该抗体基于药明生物通用型多特异性抗体专利技术平台WuXiBodyTM发现。关于Candid Therapeutics Candid Therapeutics是一家临床阶段的生物技术公司，致力于成为推动T细胞衔接子疗法用于B细胞耗竭治疗自身免疫性疾病的领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4589174_ZH89174_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1610","LU0051755006.USD","LU0417516902.SGD","BK4121","LU0456827905.SGD","LU2039709279.SGD","SG9999002463.SGD","LU0181495838.USD","LU0348825331.USD","LU1688375341.USD","LU0456846285.SGD","LU0572944931.SGD","LU0359201612.USD","LU0856984785.SGD","LU0359202008.SGD","LU0823426480.USD","LU0348735423.USD","LU1242518931.SGD","WXXWY","LU0140636845.USD","LU0039217434.USD","LU0708995583.HKD","LU1794554557.SGD","LU0979878070.USD","LU0417516738.SGD","LU0320764599.SGD","BK1521","LU0516422366.SGD","02269","LENZ","BK1576","LU0327786744.USD","LU0516423174.USD","LU0052750758.USD","LU0819121731.USD","BK1589","LU0307460666.USD","LU1720050803.USD","LU0516423091.SGD","LU0326950275.SGD","LU0516422440.USD","LU0516422952.EUR","LU1880383366.USD","LU1242518857.USD","LU0043850808.USD","LU0588546209.SGD","SG9999002562.SGD","IE00B0JY6N72.USD","BK1141","BK4139"],"gpt_icon":0},{"id":"2491833575","title":"药明生物成功入选UNGC\"‘二十年二十佳'企业可持续发展案例\"报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2491833575","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491833575?lang=zh_cn&edition=full","pubTime":"2024-12-12 16:30","pubTimestamp":1733992200,"startTime":"0","endTime":"0","summary":"引领绿色生物药发展，技术创新赋能健康未来 为全行业提供端到端绿色生物药解决方案 上海2024年12月12日 /美通社/ -- 全球领先的合同研究、开发和生产（CRDMO）服务公司药明生物（WuXi Biologics, 2269.HK）宣布，公司的绿色生物药解决方案（Green CRDMO），成功入选联合国全球契约组织（UNGC）\"‘二十年二十佳'企业可持续发展案例\"报告并受邀参加全球路演。药明","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4578414_ZH78414_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU2039709279.SGD","LU0572944931.SGD","LU0588546209.SGD","IE00B0JY6N72.USD","LU0348735423.USD","LU0823426308.USD","LU1242518857.USD","LU0307460666.USD","LU0979878070.USD","LU0516422440.USD","LU1267930730.SGD","BK1610","LU2265009873.SGD","LU0708995401.HKD","LU0039217434.USD","02269","LU0289960550.SGD","LU0052750758.USD","LU0516422366.SGD","LU0417516738.SGD","LU1880383366.USD","LU1242518931.SGD","LU2210150020.SGD","LU0516422952.EUR","LU0456827905.SGD","LU2210149790.SGD","BK1141","LU0359201612.USD","LU0051755006.USD","LU2095319765.USD","LU0326950275.SGD","BK4585","LU0823426480.USD","LU0289961442.SGD","SG9999002562.SGD","LU0672654240.SGD","LU1804176565.USD","LU1688375341.USD","MSCI","BK1589","LU0109391861.USD","WXXWY","LU0320764599.SGD","LU0043850808.USD","BK4588","ESG","LU0511384066.AUD","LU0516423174.USD","LU0359202008.SGD","LU1794554557.SGD"],"gpt_icon":1},{"id":"2489044678","title":"药明生物爱尔兰基地再迎多项里程碑：多个16000L规模PPQ生产批次成功并获HPRA GMP认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2489044678","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489044678?lang=zh_cn&edition=full","pubTime":"2024-12-06 08:02","pubTimestamp":1733443320,"startTime":"0","endTime":"0","summary":"在今年10月，药明生物爱尔兰多产品生产基地顺利通过HPRA的全面现场检查，检查范围覆盖数据管理、工艺控制、人员管理、生产、存储及分析等全流程的GMP合规性要求，并获得了GMP认证。截至目前，药明生物已成功通过全球主要药品监管机构近40次检查，并获得了67项许可证书。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4572956_ZH72956_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU0456827905.SGD","LU0516423174.USD","02269","LU1794554557.SGD","LU0823426308.USD","LU0359202008.SGD","BK1521","SG9999002463.SGD","LU0456846285.SGD","LU0708995583.HKD","LU1242518857.USD","LU0348825331.USD","LU0140636845.USD","BK1589","LU0326950275.SGD","LU0052750758.USD","LU1720050803.USD","LU0320764599.SGD","LU0043850808.USD","LU0039217434.USD","BK1610","LU0572944931.SGD","WXXWY","LU0051755006.USD","LU0359201612.USD","LU0181495838.USD","LU0979878070.USD","LU0856984785.SGD","ESG","LU0417516738.SGD","LU0348735423.USD","LU0516423091.SGD","LU0516422366.SGD","LU0819121731.USD","BK1576","BK1141","LU0516422952.EUR","LU0307460666.USD","LU0823426480.USD","LU0516422440.USD","LU1242518931.SGD","LU1688375341.USD","LU1880383366.USD","LU0588546209.SGD","BK4121","IE00B0JY6N72.USD","LU0417516902.SGD","SG9999002562.SGD","LU0327786744.USD","LU2039709279.SGD"],"gpt_icon":0},{"id":"2483897463","title":"药明生物德国基地计划扩大产能 新增预充针制剂灌装生产线","url":"https://stock-news.laohu8.com/highlight/detail?id=2483897463","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483897463?lang=zh_cn&edition=full","pubTime":"2024-11-14 12:00","pubTimestamp":1731556800,"startTime":"0","endTime":"0","summary":"德国勒沃库森2024年11月14日 /美通社/ -- 全球领先的合同研究、开发和生产服务公司药明生物宣布，公司将扩大德国勒沃库森基地产能，新建一条隔离器灌装预充针生产线。目前德国勒沃库森基地已有一条无菌灌装和冻干制剂生产线，年产能达1000万瓶，扩建后将更灵活地服务于全球客户的多元化需求。药明生物首席执行官陈智胜博士表示：\"此次扩大德国产能将进一步满足客户日益增长的制剂服务需求，特别是预充针。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4556696_ZH56696_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1589","LU1242518931.SGD","LU0359201612.USD","LU0516422366.SGD","LU0588546209.SGD","LU0456827905.SGD","LU0516423174.USD","BK1576","BK4121","SG9999002463.SGD","LU0819121731.USD","LU0181495838.USD","02269","LU1720050803.USD","LU0348825331.USD","LU0043850808.USD","SG9999002562.SGD","LU1688375341.USD","LU0140636845.USD","LU1794554557.SGD","LU0572944931.SGD","LU0320764599.SGD","ESG","BK1521","LU0051755006.USD","LU0039217434.USD","LU0052750758.USD","LU0307460666.USD","LU0516422952.EUR","LU0326950275.SGD","BK1610","LU0327786744.USD","LU0856984785.SGD","LU0979878070.USD","LU1880383366.USD","LU0516422440.USD","LU1242518857.USD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0823426480.USD","LU0456846285.SGD","LU0359202008.SGD","LU2039709279.SGD","LU0417516902.SGD","BK1141","LU0516423091.SGD","LU0348735423.USD","WXXWY","LU0417516738.SGD","LU0823426308.USD"],"gpt_icon":0},{"id":"2478171378","title":"药明生物推出技术平台WuXia™ RidGS，赋能客户研发非抗生素细胞株","url":"https://stock-news.laohu8.com/highlight/detail?id=2478171378","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478171378?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:00","pubTimestamp":1730106000,"startTime":"0","endTime":"0","summary":"WuXia RidGS衍生自WuXia细胞株构建平台，并继承了WuXia强大的细胞生长、代谢和表达水平。其单克隆抗体产品的平均克隆表达水平超过6 g/L，同时，WuXia RidGS能够确保单克隆抗体、双特异性抗体、融合蛋白和重组蛋白等多种疗法类型的细胞株稳定性。值得一提的是，在不使用抗生素情况下，WuXia RidGS宿主细胞和生产细胞在长期细胞传代中，始终保持稳定的产物表达量及产品质量。在WuXia卓越特性的基础上，WuXiaADCC Plus和WuXia RidGS积极满足全球客户的多元化需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4541340_ZH41340_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4550","LU0348825331.USD","LU0359201612.USD","BK4121","IE0004086264.USD","IE0004091025.USD","LU0708995583.HKD","LU1794554557.SGD","SG9999002463.SGD","02269","BK4504","LU2237443382.USD","LU2237443622.USD","IE00B19Z3581.USD","LU1242518857.USD","LU0348735423.USD","LU2237443895.HKD","LU0572944931.SGD","IE00B19Z3B42.SGD","LU0417516738.SGD","LU0327786744.USD","BK1576","LU0819121731.USD","IE00BFXG1179.USD","LU0456827905.SGD","LU1791807156.HKD","LU2237443549.SGD","LU0043850808.USD","LU0516423091.SGD","LU2237443465.HKD","SG9999002562.SGD","LU0516423174.USD","IE00B0JY6N72.USD","ESG","BK1521","LU1880383366.USD","LU0856984785.SGD","IE0034235188.USD","LU2039709279.SGD","WXXWY","LU1720050803.USD","LU0359202008.SGD","BK4533","IE0002270589.USD","BK4585","LU0516422366.SGD","LU2237443978.SGD","LU0823426480.USD","BK1141","LU0106831901.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.wuxibiologics.com","stockEarnings":[{"period":"1week","weight":0.0455},{"period":"1month","weight":0.056},{"period":"3month","weight":0.1404},{"period":"6month","weight":0.0218},{"period":"1year","weight":0.2475},{"period":"ytd","weight":0.6829}],"description":"药明生物技术有限公司是一家主要从事向生物制剂行业的客户提供就生物发现、开发及生产的端到端解决方案及服务的投资控股公司。该公司主要通过两个分部运营其业务。生物药分部主要从事提供生物药的发现、开发和生产。药明合联（XDC）分部主要从事为抗体偶联药物（ADCs）及各种生物偶联药物提供合同研究、开发及生产组织（CRDMO）服务。该公司主要在国内和国外市场开展其业务。","exchange":"PINK LIMITED","name":"药明生物ADR","nameEN":"Wuxi Biologics (Cayman) Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明生物ADR(WXXWY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明生物ADR(WXXWY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明生物ADR,WXXWY,药明生物ADR股票,药明生物ADR股票老虎,药明生物ADR股票老虎国际,药明生物ADR行情,药明生物ADR股票行情,药明生物ADR股价,药明生物ADR股市,药明生物ADR股票价格,药明生物ADR股票交易,药明生物ADR股票购买,药明生物ADR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明生物ADR(WXXWY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明生物ADR(WXXWY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}